Brazil · Delayed Price · Currency is BRL GPS Participações e Empreendimentos Earnings Call Transcripts
Fiscal Year 2025
-
Net revenue grew 17% year-over-year with strong organic and inorganic contributions, though margins were pressured by integration and labor costs. Strategic focus shifted to higher-value contracts, and leverage was reduced, with a robust M&A pipeline and investments in new headquarters.
-
Q3 2025 saw 8% revenue growth and 10% organic growth, with adjusted EBITDA up 3% and a 9.8% margin. M&A activity is set to accelerate as leverage normalizes, and GRCA integration is driving synergy and margin improvement. Organic growth is expected to stabilize at high single digits.
-
Q2 2025 saw 23% revenue growth and 16% higher adjusted EBITDA, with strong cash generation and a diversified customer base. Margin improvement is expected in H2 2025 as one-off costs subside, while organic growth is projected to reach 7–7.5%.
-
Net revenue rose 34% year-over-year to BRL 4.1 billion, with adjusted EBITDA up 21% and margin at 9.8%. Integration of GRSA and recent acquisitions drove diversification, while margin and labor costs faced short-term pressure. Most synergy gains are expected in the second half.
Fiscal Year 2024
-
Revenue grew 39% year-over-year to BRL 14.8 billion, driven by acquisitions and 6% organic growth, with adjusted EBITDA up 24%. Margins were slightly compressed by one-off losses and integration costs, but are expected to recover as synergies from GRSA and new acquisitions are realized.
-
Q3 2024 saw a 56% year-over-year revenue increase, driven by M&A and organic growth, with adjusted EBITDA up 41%. Integration of GRSA and other acquisitions boosted results, while margin pressure and a competitive environment persist. Leverage reduction and synergy capture are key priorities.
-
Net revenue grew 34% year-over-year to BRL 3.5 billion, driven by acquisitions, with adjusted EBITDA up 16% and margins pressured by labor costs and integration expenses. GRSA's integration is expected to deliver synergies and margin improvement by mid-2025, while M&A is paused until leverage returns to target levels.